BIIB vs DOCS · P/E 21, rev $9.89B vs P/E 21, rev $570.4M
Biogen Inc (BIIB) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Doximity Inc (DOCS) is a health information services company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Not investment advice. Open the BIIB and DOCS stock pages for the full models.
Not investment advice.